Concepedia

Author

Haichao Tang

China Medical University

Also Known As

Haichao Tang

12

Publications

376

Citations

9

H-Index

18

Concepts

All Affiliations

China Medical UniversityFourth Affiliated Hospital of China Medical UniversityLiaoning Cancer Hospital & InstituteChinese Academy of Medical Sciences & Peking Union Medical CollegeHarrison International Peace Hospital
HT

About

Haichao Tang is an author at China Medical University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

45

2

Cell Biology

2

2

30

3

Immunology

2

2

31

4

Pathology

1

1

16

5

Cancer Genetics

1

1

16

Haichao Tang

×

7

Publications

111

Citations

7

H-Index

YearCitations

HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

Zhaojin Yu, Wensi Liu, Ying He,

Journal of Hematology & Oncology

2021

23

Integrated microenvironment‐associated genomic profiles identify LRRC15 mediating recurrent glioblastoma‐associated macrophages infiltration

Haichao Tang, Wensi Liu, Zhaoxu Xu,

Journal of Cellular and Molecular Medicine

2021

16

Rescuing dendritic cell interstitial motility sustains antitumour immunity

Haichao Tang, Zongfang Wei, Bei Zheng,

Nature

2025

16

TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy

Zhaoxu Xu, Haichao Tang, Tianshu Zhang,

Life Sciences

2019

15

Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma

Wensi Liu, Zhaojin Yu, Haichao Tang,

EBioMedicine

2020

15

Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma

Qianqian Liu, Xiling Zhang, Haichao Tang,

Pathology & Oncology Research

2019

14

Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

Zhaojin Yu, Wensi Liu, Ying He,

Journal of Hematology & Oncology

2021

12

Page 1